Form 4: BioLife Solutions CFO Troy Wichterman Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Troy Wichterman, CFO of BioLife Solutions, sold 660 shares of common stock on March 3, 2025, at a price of $25.46 per share to cover tax withholding obligations related to vesting restricted stock.

Summary

  • On March 3, 2025, Troy Wichterman, the Chief Financial Officer of BioLife Solutions Inc. (BLFS), sold 660 shares of the company's common stock.
  • The sale was executed at a price of $25.46 per share.
  • Following the transaction, Wichterman directly owns 120,960 shares of BioLife Solutions.
  • The sale was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on February 24, 2022.
  • The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares under a pre-arranged trading plan to cover tax obligations.

Industry Context

Sales by company insiders are a common occurrence and are often related to personal financial planning or diversification. The use of a 10b5-1 trading plan suggests the insider's sales are pre-planned and not based on current market information.

Stakeholder Impact

  • The sale of shares by a company insider could be perceived negatively by some shareholders, although the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

DateDescription
02/24/2022Date of adoption of Rule 10b5-1(c) trading plan
03/03/2025Date of stock sale transaction
03/05/2025Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.